Celastrol recruits UBE3A to recognize and degrade the DNA binding domain of steroid receptors-Reference-Cited by-同舟云学术

Celastrol recruits UBE3A to recognize and degrade the DNA binding domain of steroid receptors

Published:2022-09-16 Issue:42 Volume:41 Page:4754-4767
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Tan Qilong,Liu Ziqun,Gao Xiaobo,Wang Yibo^ORCID,Qiu Xuefeng,Chen Jiahui,Liang Liuchun,Guo Hongqian,Huang Shengsong,Wu Denglong,Zhou Bing^ORCID,Hu Ronggui^ORCID,Li Zhenfei^ORCID

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

https://www.nature.com/articles/s41388-022-02467-8.pdf

Reference51 articles.

1. Groner AC, Brown M. Role of steroid receptor and coregulator mutations in hormone-dependent cancers. J Clin Investig. 2017;127:1126–35.

2. Tata JR. Signalling through nuclear receptors. Nat Rev Mol Cell Biol. 2002;3:702–10.

3. Chen Y, Sawyers CL, Scher HI. Targeting the androgen receptor pathway in prostate cancer. Curr Opin Pharmacol. 2008;8:440–8.

4. Furr BJ. The development of Casodex (bicalutamide): preclinical studies. Eur Urol. 1996;29:83–95. Suppl 2

5. Scher HI, Fizazi K, Saad F, Taplin ME, Sternberg CN, Miller K, et al. Increased survival with enzalutamide in prostate cancer after chemotherapy. N. Engl J Med. 2012;367:1187–97.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuronal UBE3A substrates hold therapeutic potential for Angelman syndrome;Current Opinion in Neurobiology;2024-10

2. Can Prostate Cancer Patients be Prescribed Chinese Herbal Medicine? A Review of its Potential Modulatory Effects on the Androgen Receptor;Integrative Medicine in Nephrology and Andrology;2024-07-31

3. Molecular glue degraders: exciting opportunities for novel drug discovery;Expert Opinion on Drug Discovery;2024-01-24

4. Complexity‐to‐Diversity and Pseudo‐Natural Product Strategies as Powerful Platforms for Deciphering Next‐Generation Therapeutics;ChemMedChem;2023-06-12

5. The crosstalk between ubiquitination and endocrine therapy;Journal of Molecular Medicine;2023-03-24